Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Translational Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1673132

Targeted Metabolomic Profiling Reveals Inflammation–Associated Longitudinal Changes in Plasma Metabolites Following on-pump Coronary Bypass Surgery

Provisionally accepted
Frieder  NeuFrieder Neu1,2,3Max  WackerMax Wacker4Sven  SchuchardtSven Schuchardt5Sam  VargheseSam Varghese4George  AwadGeorge Awad4Fakhar  WaqasFakhar Waqas1,2,3Jens  WippermannJens Wippermann4Frank  PesslerFrank Pessler1,2,3*Priya  VeluswamyPriya Veluswamy4
  • 1TWINCORE Zentrum fur Experimentelle und Klinische Infektionsforschung GmbH, Hanover, Germany
  • 2Medizinische Hochschule Hannover, Hanover, Germany
  • 3Helmholtz-Zentrum fur Infektionsforschung GmbH, Brunswick, Germany
  • 4Otto-von-Guericke-Universitat Magdeburg Medizinische Fakultat, Magdeburg, Germany
  • 5Fraunhofer-Institut fur Toxikologie und Experimentelle Medizin ITEM, Hanover, Germany

The final, formatted version of the article will be published soon.

Aims: Cardiac surgery leads to major post-operative changes in metabolism, but their exact nature and the underlying risk factors remains obscure. We aimed to characterize changes in plasma metabolites after coronary artery bypass grafting (CABG) to identify intra-and postoperative risk factors for global and specific alterations in plasma metabolites post-operatively. Methods: We performed a targeted metabolomic screen on plasma samples from patients undergoing on-pump CABG for coronary artery disease (CAD), collected 1 day before and 1, 3, and 7 days after surgery. We assessed correlations with parameters of intra-operative course (cardiopulmonary bypass time and aortic cross-clamping time), intensive care unit (ICU) care, (length of ICU stay, duration of mechanical ventilation, duration of epinephrine/dobutamine or norepinephrine therapy), and systemic inflammation. Results: Out of 1019 detectable analytes, 970 passed the quality screen and were included in the analysis. With respect to d0, the greatest degree of change in metabolite populations occurred by d1, but substantial changes persisted through d7. Metabolites could be classified into those which were predominantly downregulated (e.g., triglycerides, bile acids, cholesterol esters, lysophosphatidylcholines, indoles and derivatives), up-or downregulated (e.g., phosphatidylinositol, phosphatidylethanolamines, phosphatidic acids, ceramides), or upregulated (free fatty acids, monoglycerides). Concentrations of food-and/or microbiota-derived metabolites (indole derivatives, trimethylamine N-oxide, trigonelline) were markedly reduced particularly on d1 and d3. Changes in metabolite concentrations correlated most strongly with plasma C-reactive protein concentration (r = -0.67 to 0.59) and blood leukocyte count (-0.63 to 0.32) and less with intra-operative (-0.62 to 0.50) and ICU care (-0.52 to 0.38) parameters. Of note, neither C-reactive protein (CRP) nor leukocyte count correlated significantly with an intra-operative or ICU parameter. Conclusions: These results reveal pronounced changes in plasma metabolite populations after CABG, which likely result from the combined effects of surgical and post-operative stress, systemic inflammation, reduced dietary intake, and possibly changes in gut microflora.

Keywords: Bile acids, biomarkers, Coronary Artery Disease, Coronary artery bypass graft, free fatty acids, Metabolomics, Phosphatidylcholine, Plasma metabolites

Received: 25 Jul 2025; Accepted: 29 Sep 2025.

Copyright: © 2025 Neu, Wacker, Schuchardt, Varghese, Awad, Waqas, Wippermann, Pessler and Veluswamy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Frank Pessler, frank.pessler@twincore.de

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.